Loading institutional data...
Loading institutional data...
Held by 212 of 5,944 reporting institutions (92th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $33.13 today, the market must believe free cash flow compounds 23.2%/yr for a decade (off $23M normalized FCF).
The market's 23.2% is more conservative than its 4-yr track record.
2-stage DCF · 0.04B shares · net debt $177M
mean -613.5% · volatility σ 688% · implied rate exceeded in 0/2 yrs
Central path = implied 23.2%/yr growth; shaded band = ±1σ (688%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $43M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: -2%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $73M covers the $9M due within a year 7.8× over. Scheduled principal only (excludes interest & revolver draws). As of 2021-09-30 (10-Q).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~9.7% on $250M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $272.3M 100.0% | $199.6M 100.0% | $130.2M 100.0% | $88.6M 100.0% | $72.5M 100.0% | $48.9M 100.0% | $51.2M 100.0% | $41.4M 100.0% | $26.8M 100.0% | $19.9M 100.0% |
| Cost of Revenue | $67.9M 24.9% | $49.2M 24.7% | $39.6M 30.4% | $25.4M 28.7% | $18.2M 25.1% | $14.5M 29.6% | $16.7M 32.7% | $16.5M 39.9% | $13.5M 50.4% | — |
| Gross Profit | $204.4M 75.1% | $150.4M 75.3% | $90.6M 69.6% | $63.2M 71.3% | $54.3M 74.9% | $34.4M 70.4% | $34.4M 67.3% | $24.9M 60.1% | $13.3M 49.6% | $10.1M 50.7% |
| Research & Development | $20.9M 7.7% | $12.2M 6.1% | $6.7M 5.1% | $3.0M 3.4% | $11.1M 15.3% | $2.4M 4.9% | $2.1M 4.1% | $825K 2.0% | $413K 1.5% | $739K 3.7% |
| Selling, General & Admin | $152.9M 56.2% | $129.1M 64.7% | $83.1M 63.8% | $58.2M 65.7% | $41.3M 57.0% | $31.2M 63.9% | $33.1M 64.7% | $29.2M 70.7% | $25.0M 93.4% | $17.6M 88.1% |
| Total Operating Expenses | $173.9M 63.8% | $141.5M 70.9% | $90.1M 69.2% | $61.3M 69.2% | $52.6M 72.6% | $34.0M 69.6% | $39.2M 76.6% | $30.1M 72.7% | $25.4M 95.0% | — |
| Operating Income | $30.5M 11.2% | $8.8M 4.4% | $431K 0.3% | $1.9M 2.2% | $1.6M 2.2% | $385K 0.8% | -$4.8M -9.4% | -$5.2M -12.6% | -$12.2M -45.4% | -$15.9M -79.6% |
| Interest Expense | $24.2M 8.9% | $22.8M 11.4% | $21.3M 16.4% | $7.2M 8.2% | $5.4M 7.5% | — | — | — | — | — |
| Other Income (Expense), net | -$31.9M -11.7% | -$26.1M -13.1% | -$24.1M -18.5% | -$15.9M -18.0% | -$19.5M -26.9% | -$3.8M -7.8% | $4.7M 9.1% | $19.8M 48.0% | -$757K -2.8% | -$3.3M -16.6% |
| Pretax Income | -$1.4M -0.5% | -$17.3M -8.7% | -$23.7M -18.2% | -$14.0M -15.8% | -$17.9M -24.7% | -$3.4M -7.0% | -$117K -0.2% | $14.6M 35.3% | -$12.9M -48.3% | -$19.2M -96.3% |
| Income Tax Expense | $3.8M 1.4% | $161K 0.1% | $701K 0.5% | $75K 0.1% | $133K 0.2% | $4K 0.0% | $8K 0.0% | — | -$935K -3.5% | -$111K -0.6% |
| Net Income | -$5.1M -1.9% | -$17.5M -8.8% | -$24.4M -18.7% | -$14.1M -15.9% | -$18.0M -24.8% | -$3.4M -6.9% | $168K 0.3% | $14.6M 35.3% | -$12.0M -44.8% | -$19.1M -95.7% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.14 | $-0.49 | $-0.75 | $-0.51 | $-0.69 | $-0.13 | $0.01 | $0.67 | $-0.60 | — |
| EPS (Diluted) | $-0.14 | $-0.49 | $-0.75 | $-0.51 | — | $-0.13 | $0.01 | $0.61 | $-0.60 | — |
| Weighted Avg Shares (Basic) | 36.8M | 35.7M | 32.6M | 27.5M | 26.8M | 25.9M | 25.3M | 21.9M | 20.0M | — |
| Weighted Avg Shares (Diluted) | 36.8M | 35.7M | 32.6M | 27.5M | — | 25.9M | 26.5M | 23.8M | 20.0M | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-09-17
Where each multiple sits in its own 14-yr range · 73th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 6.8× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 39.9 | 32.7 | 29.6 | 25.1 | 28.7 | 30.4 | 24.7 | 24.9 |
| Gross Profit | 60.1 | 67.3 | 70.4 | 74.9 | 71.3 | 69.6 | 75.3 | 75.1 |
| R&D | 2.0 | 4.1 | 4.9 | 15.3 | 3.4 | 5.1 | 6.1 | 7.7 |
| SG&A | 70.7 | 64.7 | 63.9 | 57.0 | 65.7 | 63.8 | 64.7 | 56.2 |
| Operating Income | -12.6 | -9.4 | 0.8 | 2.2 | 2.2 | 0.3 | 4.4 | 11.2 |
| Income Tax | — | 0.0 | 0.0 | 0.2 | 0.1 | 0.5 | 0.1 | 1.4 |
| Net Income | 35.3 | 0.3 | -6.9 | -24.8 | -15.9 | -18.7 | -8.8 | -1.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on HROW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| HROW | $1.2B | — | — | 4.5× | 36.4% | 75.1% | -1.9% | -9.8% | -1.7% | — | 212 |
Peers = companies sharing HROW's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.